Fiche centre
Novartis Investigative Site
Salford — United Kingdom
Essais liés3clinical trials
VilleSalfordlocalisation
PaysUnited Kingdomlocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07094516
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL | Maladie coronarienne | Phase 3 | NCT05739383 | A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. | ACTIVE_NOT_RECRUITING |
| VHB937 | Alzheimer | Phase 2 | NCT07094516 | A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease | ACTIVE_NOT_RECRUITING |
| Ofatunumab | SEP | Phase 4 | NCT06444113 | KATHAROS — Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis | ACTIVE_NOT_RECRUITING |